Skip to main content
SpringerLink
Log in

Carcinoid Tumours of the Gastrointestinal System: Neuroendocrine Tumours of the Hindgut

  • Chapter
  • First Online:
Evidence-Based Endocrine Surgery

  • 583 Accesses

Abstract

Carcinoids are neuroendocrine tumours (NETs), small, slow-growing neoplasms, characterised by their ability to store and secrete different peptides and neuroamines [1, 2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Vinik AI, Woltering EA, Warner RRP, et al. NANETS Consensus guidelines for the diagnosis of neuroendocrine tumours. Pancreas. 2010;39(6):713–34.

    Article  Google Scholar 

  2. Massironi S, Sciola V, Peracchi M, et al. Neuroendocrine tumors of the gastro-entero-pancreatic system. World J Gastroenterol. 2008;14:5377–84.

    Article  Google Scholar 

  3. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934–59.

    Article  Google Scholar 

  4. Langhans T. Ueber einen drusenpolyp im ileum. Virchow Arch Pathol Anat Physiol Klin Med. 1867;38:559–60.

    Article  Google Scholar 

  5. Ransom WB. A case of primary carcinoma of the ileum. Lancet. 1890;2:1020–3.

    Article  Google Scholar 

  6. Oberndorfer S. Karzenoide tumoren des dünndarms. Frankf Zschr Path. 1907;1:426–30.

    Google Scholar 

  7. Gosset A, Masson P. Tumeurs endocrines de l’appendice. Presse Med. 1914;25:237–9.

    Google Scholar 

  8. Godwin JD II. Carcinoid tumors, an analysis of 2837 cases. Cancer. 1975;36:560–9.

    Article  Google Scholar 

  9. Modlin IM, Sandor A. An analysis of 8305 carcinoid tumors. Cancer. 1997;79:813–29.

    Article  CAS  Google Scholar 

  10. Yao JC, Phan AT, Chang DZ, et al. Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study. [Erratum appears in J Clin Oncol. 2008; 26(34): 5660.]. J Clin Oncol. 2008;1926:4311–8.

    Article  Google Scholar 

  11. Anthony LB, Strosberg JR, Klimstra DS, et al. The NANETS Consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumours (NETs) – well differentiated NETs of the distal colon and rectum. Pancreas. 2010;39(6):767–74.

    Article  Google Scholar 

  12. Kvols LK, Brendtro KL. The North American Neuroendocrine Tumor Society (NANETS) Guidelines – mission, goals, and process. Pancreas. 2010;39(6):705–6.

    Article  Google Scholar 

  13. Edge SB, Byrd DR, Compton CC. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.

    Google Scholar 

  14. Rindi G, Kloppel G, Couvelard A, et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2007;451(4):757–62.

    Article  CAS  Google Scholar 

  15. Wang AY, Ahmad NA. Rectal carcinoids [Review]. Curr Opin Gastroenterol. 2006;22(5):529–35.

    Article  Google Scholar 

  16. Shim KN, Yang SK, Myung SJ, et al. Atypical endoscopic features of rectal carcinoids. Endoscopy. 2004;36(4):313–6.

    Article  Google Scholar 

  17. Kobayashi K, Katsumata T, Yoshizawa S, et al. Indications of endoscopic polypectomy for rectal carcinoid tumors and clinical usefulness of endoscopic ultrasonography. Dis Colon Rectum. 2005;48(2):285–91.

    Article  Google Scholar 

  18. Fujishima H, Misawa T, Maruoka A, et al. Rectal carcinoid tumor: endoscopic ultrasonographic detection and endoscopic removal. Eur J Radiol. 1993;16(3):198–200.

    Article  CAS  Google Scholar 

  19. Lin O, Olgac S, Green I, et al. Immunohistochemical staining of cytologic smears with MIB-1 helps distinguish low-grade from high-grade neuroendocrine neoplasms. Am J Clin Pathol. 2003;120(2):209–16.

    Article  Google Scholar 

  20. Pelosi G, Rodriguez J, Viale G, et al. Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients. Am J Surg Pathol. 2005;29(2):179–87.

    Article  Google Scholar 

  21. Mani S, Modlin IM, Ballantyne G, et al. Carcinoids of the rectum [Review]. J Am Coll Surg. 1994;179(2):231–48.

    CAS  PubMed  Google Scholar 

  22. Eriksson B, Oberg K, Stridsberg M, et al. Tumor markers in neuroendocrine tumors [Review]. Digestion. 2000;62(suppl 1):33–8.

    Article  CAS  Google Scholar 

  23. O’Connor DT, Deftos LJ. Secretion of chromogranin A by peptide-producing endocrine neoplasms. New Engl J Med. 1986;314(18):1145–51.

    Article  Google Scholar 

  24. Nobels FR, Kwekkeboom DJ, Bouillon R, et al. Chromogranin A: its clinical value as marker of neuroendocrine tumours. Eur J Clin Invest. 1998;28:431–40.

    Article  CAS  Google Scholar 

  25. Jensen EH, Kvols L, McLoughlin JM, et al. Biomarkers predict outcomes following cytoreductive surgery for hepatic metastases from functional carcinoid tumors. Ann Surg Oncol. 2007;14:780–5.

    Article  Google Scholar 

  26. Nobels FR, Kwekkeboom DJ, Coopmans W, et al. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. J Clin Endocrinol Metab. 1997;82:2622–8.

    CAS  PubMed  Google Scholar 

  27. Stridsberg M, Eriksson B, Fellstrom B, et al. Measurements of chromogranin B can serve as a complement to chromogranin A. Regul Pept. 2007;139:80–3.

    Article  CAS  Google Scholar 

  28. Berge T, Linell F. Carcinoid tumors. Frequency in a defined population during a 12-year-period. Acta Pathol Microbiol Scand. 1976;84:322–30.

    CAS  Google Scholar 

  29. Saha S, Hoda S, Godfrey R, Sutherland C, Raybon K. Carcinoid tumors of the gastrointestinal tract: a 44-year experience. South Med J. 1989;82:1501–5.

    Article  CAS  Google Scholar 

  30. Marshall JB, Bodnarchuk G. Carcinoid tumors of the gut. J Clin Gastroenterol. 1993;16:123–9.

    Article  CAS  Google Scholar 

  31. Olney JR, Urdaneta LF, Al-Jurf AS, Jochimsen PR, Shirazi SS. Carcinoid tumors of the gastrointestinal tract. Am Surg. 1985;51:37–41.

    CAS  PubMed  Google Scholar 

  32. Oberg K. Expression of growth factors and their receptors in neuroendocrine gut and pancreatic tumors, and prognostic factors for survival. Ann N Y Acad Sci. 1994;733:46–55.

    Article  CAS  Google Scholar 

  33. Modlin IM, Goldenring JR, Lawton GP, Hunt R. Aspects of the theoretical basis and clinical relevance of low acid states. Am J Gastroenterol. 1994;89:308–18.

    CAS  PubMed  Google Scholar 

  34. Berkelhammer C, Jasper I, Kirvaitis E, et al. “Band-snare” resection of small rectal carcinoid tumors. Gastrointest Endosc. 1999;50(4):582–5.

    Article  CAS  Google Scholar 

  35. Fujishiro M, Yahagi N, Nakamura M, et al. Successful outcomes of a novel endoscopic treatment for GI tumors: endoscopic submucosal dissection with a mixture of high-molecular-weight hyaluronic acid, glycerin, and sugar. Gastrointest Endosc. 2006;63(2):243–9.

    Article  Google Scholar 

  36. Ono A, Fujii T, Saito Y, et al. Endoscopic submucosal resection of rectal carcinoid tumors with a ligation device. Gastrointest Endosc. 2003;57(4):583–7.

    Article  Google Scholar 

  37. Okamoto Y, Fujii M, Tateiwa S, et al. Treatment of multiple rectal carcinoids by endoscopic mucosal resection using a device for esophageal variceal ligation. Endoscopy. 2004;36(5):469–70.

    Article  CAS  Google Scholar 

  38. Imada-Shirakata Y, Sakai M, Kajiyama T, et al. Endoscopic resection of rectal carcinoid tumors using aspiration lumpectomy. Endoscopy. 1997;29(1):34–8.

    Article  CAS  Google Scholar 

  39. Schindl M, Niederle B, Hafner M, et al. Stage-dependent therapy of rectal carcinoid tumors. World J Surg. 1998;22(6):628–33.

    Article  CAS  Google Scholar 

  40. Buess G, Hutterer F, Theiss J, et al. A system for a transanal endoscopic rectum operation. [in German]. Chirurg. 1984;55(10):677–80.

    CAS  PubMed  Google Scholar 

  41. Kinoshita T, Kanehira E, Omura K, et al. Transanal endoscopic microsurgery in the treatment of rectal carcinoid tumor. Surg Endosc. 2007;21(6):970–4.

    Article  CAS  Google Scholar 

  42. Tsai BM, Finne CO, Nordenstam JF, et al. Transanal endoscopic microsurgery resection of rectal tumors: outcomes and recommendations. Dis Colon Rectum. 2010;53(1):16–23.

    Article  Google Scholar 

  43. Arnold R, Trautmann ME, Creutzfeldt W, et al. Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut. 1996;38(3):430–8.

    Article  CAS  Google Scholar 

  44. Ducreux M, Ruszniewski P, Chayvialle JA, et al. The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors. Am J Gastroenterol. 2000;95(11):3276–81.

    Article  CAS  Google Scholar 

  45. Koizumi M, Onda M, Tanaka N, et al. Antiangiogenic effect of octreotide inhibits the growth of human rectal neuroendocrine carcinoma. Digestion. 2002;1965:200–6.

    Article  Google Scholar 

  46. Arnold R, Rinke A, Klose KJ, et al. Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial. Clin Gastroenterol Hepatol. 2005;3(8):761–71.

    Article  CAS  Google Scholar 

  47. Kolby L, Persson G, Franzen S, et al. Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours. Br J Surg. 2003;1990:687–93.

    Article  Google Scholar 

  48. Eriksson BK, Larsson EG, Skogseid BM, et al. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors. Cancer. 1998;83(11):2293–301.

    Article  CAS  Google Scholar 

  49. Gupta S, Yao JC, Ahrar K, et al. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience. Cancer J. 2003;9(4):261–7.

    Article  Google Scholar 

  50. Strosberg JR, Choi J, Cantor AB, et al. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors. Cancer Control. 2006;13(1):72–8.

    Article  Google Scholar 

  51. Norton JA, Warren RS, Kelly MG, et al. Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery. 2003;134(6):1057–63.

    Article  Google Scholar 

  52. Osborne DA, Zervos EE, Strosberg J, et al. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors. [erratum appears in Ann Surg Oncol. 2006;13(8):1162. Note: Strosberg, Jonathon [corrected to Strosberg, Jonathan]]. Ann Surg Oncol. 2006;13(4):572–81.

    Article  Google Scholar 

  53. Sarmiento JM, Que FG, Sarmiento JM, et al. Hepatic surgery for metastases from neuroendocrine tumors. Surg Oncol Clin N Am. 2003;12(1):231–42.

    Article  Google Scholar 

  54. Boudreaux JP, Putty B, Frey DJ, et al. Surgical treatment of advanced-stage carcinoid tumors: lessons learned. Ann Surg. 2005;241:839–45.

    Article  Google Scholar 

  55. http://www.cancer.org/acs/groups/cid/documents/webcontent/003102-pdf.pdf.

  56. Landry CS, Brock G, Scoggins CR, et al. A proposed staging system for rectal carcinoid tumors based on an analysis of 4701 patients. Surgery. 2008;144(3):460–6.

    Article  Google Scholar 

  57. Fahy BN, Tang LH, Klimstra D, et al. Carcinoid of the rectum risk stratification (CaRRS): a strategy for preoperative outcome assessment. Ann Surg Oncol. 2007;14(2):396–404.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Colorectal Surgery, University Surgical Cluster, National University Hospital, Singapore, Singapore

    Bettina Lieske

Authors
  1. Bettina Lieske
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bettina Lieske .

Editor information

Editors and Affiliations

  1. Division of Endocrine Surgery, National University Hospital, Singapore, Singapore

    Rajeev Parameswaran

  2. Department of Endocrine Surgery, SGPGI Hospital, Lucknow, India

    Amit Agarwal

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media Singapore

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lieske, B. (2018). Carcinoid Tumours of the Gastrointestinal System: Neuroendocrine Tumours of the Hindgut. In: Parameswaran, R., Agarwal, A. (eds) Evidence-Based Endocrine Surgery. Springer, Singapore. https://doi.org/10.1007/978-981-10-1124-5_37

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-1124-5_37

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-1123-8

  • Online ISBN: 978-981-10-1124-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation